We are live on
!
Find out more
M
Mirova Portfolio holdings
AUM
$2.46B
1-Year Est. Return
11.42%
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
+11.42%
3 Year Est. Return
+32%
5 Year Est. Return
+23.08%
10 Year Est. Return
–
AUM
$1.13B
AUM Growth
+$947M
(+513%)
Cap. Flow
+$898M
Cap. Flow
% of AUM
79.4%
Top 10 Holdings %
Top 10 Hldgs %
69.13%
Holding
135
New
36
Increased
32
Reduced
8
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$82.9M |
| 2 |
Mastercard
MA
|
+$80.3M |
| 3 |
Microsoft
MSFT
|
+$80.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$74M |
| 5 |
Danaher
DHR
|
+$73.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Solar
FSLR
|
+$1.63M |
| 2 |
Johnson & Johnson
JNJ
|
+$302K |
| 3 |
Abbott
ABT
|
+$251K |
| 4 |
Voya Financial
VOYA
|
+$207K |
| 5 |
Rockwell Automation
ROK
|
+$172K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.22% |
| 2 | Technology | 22.57% |
| 3 | Financials | 15.14% |
| 4 | Materials | 10.65% |
| 5 | Utilities | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UN
126
DELISTED
Unilever NV New York Registry Shares
UN
| $24K | ﹤0.01% |
+403
| New | +$24.1K |
|
127
Enbridge
ENB
$121B
| $23K | ﹤0.01% |
633
| – | – |
|
128
ASML
ASML
$608B
| $16K | ﹤0.01% |
+78
| New | +$15.5K |
|
129
Kontoor Brands
KTB
$4.87B
| $7K | ﹤0.01% |
+164
| New | +$4.87K |
|
|
130
Abbott
ABT
$187B
| – | – |
-3,134
| Closed | -$251K |
|
|
131
Johnson & Johnson
JNJ
$643B
| – | – |
-2,159
| Closed | -$302K |
|
|
132
Rockwell Automation
ROK
$52.4B
| – | – |
-980
| Closed | -$172K |
|
|
133
Voya Financial
VOYA
$9.07B
| – | – |
-4,137
| Closed | -$207K |
|
|
WCN
134
Waste Connections
WCN
$42.7B
| – | – |
-1,124
| Closed | -$100K |
|
|
DISCK
135
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| – | – |
-1,128
| Closed | -$29K |
|
Similar funds
BW
SCM
GWM
TW
JC
SG
RL
QT
Mirova's Q2 2019 Portfolio in Review
As of Q2 2019, Mirova held 135 positions worth $1.13B, up 513% from $184M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Mirova deployed $898M of net new capital in Q2 2019, opening 36 new positions and adding to 32 existing holdings. Its largest new stake was Church & Dwight Co: 39,716 shares worth $2.9M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was First Solar, an estimated $1.63M trimmed.
- Mirova's largest Q2 2019 buy was Church & Dwight Co: 39,716 shares worth $2.9M.
- Mirova added most to Thermo Fisher Scientific in Q2 2019, an estimated $82.9M increase.
- Mirova's biggest Q2 2019 reduction was First Solar, cutting an estimated $1.63M.
- Mirova fully exited Johnson & Johnson in Q2 2019, selling an estimated $302K.
- Mirova's ten largest holdings make up 69% of its $1.13B portfolio in Q2 2019.
- Mirova opened 36 new positions and closed 6 in Q2 2019.
- Mirova's portfolio value rose 513% quarter-over-quarter to $1.13B.
Based on Mirova's 13F filing for Q2 2019, filed 13 Aug 2019.